144 related articles for article (PubMed ID: 23471718)
1. Clinical implications of CIP2A protein expression in breast cancer.
Yu G; Liu G; Dong J; Jin Y
Med Oncol; 2013 Jun; 30(2):524. PubMed ID: 23471718
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of sCIP2A levels in breast cancer.
Xing ML; Lu YF; Wang DF; Zou XY; Zhang SX; Yun Z
Eur Rev Med Pharmacol Sci; 2016; 20(1):82-91. PubMed ID: 26813457
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of vasculogenic mimicry, PRRX1, and CIP2A in clear cell renal cell carcinoma and its clinicopathological significance.
Wang X; Yang R; Wang Q; Wang Y; Ci H; Wu S
Medicine (Baltimore); 2019 Sep; 98(36):e17028. PubMed ID: 31490389
[TBL] [Abstract][Full Text] [Related]
4. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.
Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB
Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565
[TBL] [Abstract][Full Text] [Related]
5. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.
Ren J; Li W; Yan L; Jiao W; Tian S; Li D; Tang Y; Gu G; Liu H; Xu Z
Br J Cancer; 2011 Dec; 105(12):1905-11. PubMed ID: 22075943
[TBL] [Abstract][Full Text] [Related]
6. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
7. CIP2A overexpression is associated with c-Myc expression in colorectal cancer.
Böckelman C; Koskensalo S; Hagström J; Lundin M; Ristimäki A; Haglund C
Cancer Biol Ther; 2012 Mar; 13(5):289-95. PubMed ID: 22310977
[TBL] [Abstract][Full Text] [Related]
8. CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.
Wang L; Gu F; Ma N; Zhang L; Bian JM; Cao HY
Tumour Biol; 2013 Aug; 34(4):2309-13. PubMed ID: 23568706
[TBL] [Abstract][Full Text] [Related]
9. CIP2A is associated with human breast cancer aggressivity.
Côme C; Laine A; Chanrion M; Edgren H; Mattila E; Liu X; Jonkers J; Ivaska J; Isola J; Darbon JM; Kallioniemi O; Thézenas S; Westermarck J
Clin Cancer Res; 2009 Aug; 15(16):5092-100. PubMed ID: 19671842
[TBL] [Abstract][Full Text] [Related]
10. Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy.
Chen KF; Yen CC; Lin JK; Chen WS; Yang SH; Jiang JK; Lan YT; Lin CC; Yu HC; Hsu HM; Lin WL; Teng HW
BMC Cancer; 2015 Apr; 15():301. PubMed ID: 25896895
[TBL] [Abstract][Full Text] [Related]
11. CIP2A is a target of bortezomib in human triple negative breast cancer cells.
Tseng LM; Liu CY; Chang KC; Chu PY; Shiau CW; Chen KF
Breast Cancer Res; 2012 Apr; 14(2):R68. PubMed ID: 22537901
[TBL] [Abstract][Full Text] [Related]
12. Assessment of CIP2A and ROCK-I expression and their prognostic value in breast cancer.
Tawab Osman N; Khalaf M; Ibraheem S
Pol J Pathol; 2020; 71(2):87-98. PubMed ID: 32729299
[TBL] [Abstract][Full Text] [Related]
13. Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.
Routila J; Bilgen T; Saramäki O; Grénman R; Visakorpi T; Westermarck J; Ventelä S
J Oral Pathol Med; 2016 May; 45(5):329-37. PubMed ID: 26436875
[TBL] [Abstract][Full Text] [Related]
14. CIP2A expression predicts recurrences of tamoxifen-treated breast cancer.
Baldacchino S; Wastall LM; Saliba C; Hughes TA; Scerri C; Berwick A; Speirs V; Hanby AM; Grech G
Tumour Biol; 2017 Oct; 39(10):1010428317722064. PubMed ID: 29034804
[TBL] [Abstract][Full Text] [Related]
15. Relationship between CIP2A expression, and prognosis and MDR-related proteins in patients with advanced gastric cancer.
Chen JS; Wu BB; Bao HL; Du JM; Zhang SC; Zheng YH
Int J Clin Exp Pathol; 2015; 8(11):15007-12. PubMed ID: 26823836
[TBL] [Abstract][Full Text] [Related]
16. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
[TBL] [Abstract][Full Text] [Related]
17. Nanog: a potential biomarker for liver metastasis of colorectal cancer.
Xu F; Dai C; Zhang R; Zhao Y; Peng S; Jia C
Dig Dis Sci; 2012 Sep; 57(9):2340-6. PubMed ID: 22562535
[TBL] [Abstract][Full Text] [Related]
18. [Expression of cancerous inhibitor of protein phosphatase 2A in tissue microarray of colorectal cancer and its clinical significance].
Peng XY; Chen W; Zhou K; Fu JP; Fu P; Zeng QL
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1102-6. PubMed ID: 24277410
[TBL] [Abstract][Full Text] [Related]
19. Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray.
Guo J; Gong G; Zhang B
Tumour Biol; 2017 Jul; 39(7):1010428317713392. PubMed ID: 28671019
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of TMPRSS4 expression in patients with breast cancer.
Liang B; Wu M; Bu Y; Zhao A; Xie F
Med Oncol; 2013 Jun; 30(2):497. PubMed ID: 23420063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]